Brainsway Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Brainsway Ltd., a foreign private issuer, on October 16, 2023. The report covers the month of October 2023 and is incorporated by reference into the Company's Registration Statements on Form S-8 and Form F-3.
Key Financial Metrics
The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity metrics. This report serves as a notification of a corporate event rather than a financial statement.
Material Changes
The primary material event disclosed is the publication of study data regarding Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) for the treatment of depression. No financial changes versus prior periods are detailed in this document.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the study data publication. The filing does not contain updated financial guidance, specific risk factors, contingencies, or details on unusual items beyond the referenced clinical study.
Investor Verification Checklist
- Verify the full text and clinical outcomes of the published study data on Accelerated Deep TMS for depression.
- Review the referenced Registration Statements (S-8 and F-3) for broader context on the company's capital structure.
- Check subsequent filings for any financial impact resulting from the study publication.